主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
KIDS
#2574
OrthoPediatrics Corp. Common Stock
19.170
0
+12.24%
版块:
基础:
利润货币:
日范围
年范围
日变化
+12.24%
每月变动
+7.88%
6个月变化
+12.57%
年变化
+12.57%
前一天收盘价
17.080
0
Open
19.170
0
Bid
Ask
Low
19.170
0
High
19.170
0
交易量
43
市场
股票
医疗保健
KIDS
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2020
2021
2022
2023
2024
Total assets
320.41 M
304.27 M
427.73 M
438.75 M
473.21 M
Total liabilities
85.64 M
78.91 M
49.08 M
61.72 M
118.64 M
Total equity
234.77 M
225.37 M
378.65 M
377.02 M
354.57 M
Total liabilities & shareholders' equities
320.41 M
304.27 M
427.73 M
438.75 M
473.21 M
Total debt
—
—
—
—
—
Net debt
—
—
—
—
—
OrthoPediatrics Corp
OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.
新闻
Needham上调OrthoPediatrics股价目标至30美元,看好增长前景
Needham raises OrthoPediatrics stock price target to $30 on growth
OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates
Meta Goes to Trial in a New Mexico Child Safety Case. Here’s What’s at Stake
FDA批准iotaMotion的人工耳蜗植入系统用于4岁及以上儿童
FDA clears iotaMotion’s cochlear implant system for children from age four
TD Cowen 对 OrthoPediatrics 股票启动覆盖并给予买入评级
TD Cowen initiates coverage on OrthoPediatrics stock with Buy rating
Meta Seeks to Bar Mentions of Mental Health—and Zuckerberg’s Harvard Past—From Child Safety Trial
OrthoPediatrics (KIDS) Moves 9.8% Higher: Will This Strength Last?
OrthoPediatrics公司2025年创纪录收入达2.361亿美元
OrthoPediatrics reports record 2025 revenue of $236.1 million